Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)
Clinical trial NCT03050866 · UNKNOWN
Trial details
- NCT number
- NCT03050866
- Sponsor
- Erasmus Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-21
- Primary completion
- 2022-01-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.